Alphabet is an investment fund managing more than $1.97 trillion ran by Marsida Saraci. There are currently 42 companies in Mrs. Saraci’s portfolio. The largest investments include GitLab and Arm Holdings Plc, together worth $806 billion.
As of 26th July 2024, Alphabet’s top holding is 9,758,333 shares of GitLab currently worth over $485 billion and making up 24.6% of the portfolio value.
Relative to the number of outstanding shares of GitLab, Alphabet owns less than 0.8% of the company.
In addition, the fund holds 1,960,784 shares of Arm Holdings Plc worth $321 billion.
The third-largest holding is Revolution Medicines Inc worth $206 billion and the next is Crowdstrike Inc worth $164 billion, with 427,895 shares owned.
Currently, Alphabet's portfolio is worth at least $1.97 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Alphabet office and employees reside in Mountain View, California. According to the last 13-F report filed with the SEC, Marsida Saraci serves as the Vice President, Deputy Controller at Alphabet.
In the most recent 13F filing, Alphabet revealed that it had opened a new position in
Tempus Ai Inc and bought 1,551,102 shares worth $54.3 billion.
The investment fund also strengthened its position in Revolution Medicines Inc by buying
5,563 additional shares.
This makes their stake in Revolution Medicines Inc total 5,307,075 shares worth $206 billion.
Revolution Medicines Inc soared 39.2% in the past year.
On the other hand, there are companies that Alphabet is getting rid of from its portfolio.
Alphabet closed its position in Invivyd Inc on 2nd August 2024.
It sold the previously owned 4,527,122 shares for $20.1 billion.
Marsida Saraci also disclosed a decreased stake in Crowdstrike Inc by 0.5%.
This leaves the value of the investment at $164 billion and 427,895 shares.
The two most similar investment funds to Alphabet are Seizert Capital Partners and Nicholas Hoffman ,. They manage $1.97 trillion and $1.97 trillion respectively.
Alphabet’s portfolio is diversified across 3 sectors.
Currently, their heaviest sector is Technology — making up 41.3% of
the total portfolio value.
The fund focuses on investments in the United States as
50.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
10% of the total holdings value.
On the other hand, small-cap stocks make up only 4.8% of the portfolio.
The average market cap of the portfolio companies is close to $7.58 billion.
These positions were updated on August 2nd based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| GitLab Inc. |
No change
9,758,333
|
$485,184,317,000 | 24.58% |
| Arm Holdings Plc |
No change
1,960,784
|
$320,823,478,000 | 16.25% |
| Revolution Medicines Inc |
0.10%
5,307,075
|
$205,967,580,000 | 10.43% |
| Crowdstrike Holdings Inc |
50.00%
427,895
|
$163,965,085,000 | 8.31% |
| Freshworks Inc |
No change
12,336,643
|
$156,551,999,000 | 7.93% |
| Dexcom Inc |
42.10%
1,036,937
|
$117,567,917,000 | 5.96% |
| UiPath, Inc. |
No change
7,034,337
|
$89,195,393,000 | 4.52% |
| Prime Medicine Inc |
No change
15,062,498
|
$77,421,240,000 | 3.92% |
| Snowflake Inc. |
No change
535,604
|
$72,354,744,000 | 3.66% |
| Verve Therapeutics Inc |
No change
12,349,086
|
$60,263,539,000 | 3.05% |
| Planet Labs Pbc |
No change
31,942,641
|
$59,413,312,000 | 3.01% |
| Tempus Ai Inc |
Opened
1,551,102
|
$54,288,570,000 | 2.75% |
| Invivyd Inc |
Closed
4,527,122
|
$20,100,421,000 | |
| Sana Biotechnology Inc |
No change
2,812,500
|
$15,356,250,000 | 0.78% |
| Relay Therapeutics, Inc. |
No change
1,568,753
|
$10,228,270,000 | 0.52% |
| Desktop Metal, Inc. |
Closed
11,048,730
|
$9,722,882,000 | |
| Vera Therapeutics Inc |
No change
241,264
|
$8,728,932,000 | 0.44% |
| Lyell Immunopharma Inc |
No change
5,865,125
|
$8,504,431,000 | 0.43% |
| Oscar Health, Inc. |
No change
481,988
|
$7,625,050,000 | 0.39% |
| Beam Therapeutics Inc. |
No change
321,604
|
$7,535,182,000 | 0.38% |
| Tscan Therapeutics Inc |
No change
1,077,080
|
$6,300,918,000 | 0.32% |
| Illumina Inc |
No change
53,470
|
$5,581,199,000 | 0.28% |
| Monte Rosa Therapeutics Inc |
No change
1,464,015
|
$5,475,416,000 | 0.28% |
| Dianthus Therapeutics Inc |
No change
208,697
|
$5,401,078,000 | 0.27% |
| Desktop Metal, Inc. |
Opened
1,104,871
|
$4,563,117,000 | 0.23% |
| Foghorn Therapeutics Inc. |
No change
500,901
|
$2,880,181,000 | 0.15% |
| Tenaya Therapeutics Inc |
No change
915,705
|
$2,838,686,000 | 0.14% |
| Fractyl Health Inc |
No change
662,584
|
$2,829,234,000 | 0.14% |
| Autolus Therapeutics plc |
No change
698,262
|
$2,429,952,000 | 0.12% |
| Benson Hill Inc |
No change
15,352,271
|
$2,302,841,000 | 0.12% |
| Barinthus Biotherapeutics Pl |
No change
1,513,644
|
$2,119,102,000 | 0.11% |
| Kronos Bio, Inc. |
No change
1,438,232
|
$1,783,408,000 | 0.09% |
| Rani Therapeutics Hldgs Inc |
No change
448,492
|
$1,704,270,000 | 0.09% |
| RAPT Therapeutics, Inc. |
No change
540,270
|
$1,647,824,000 | 0.08% |
| Taysha Gene Therapies, Inc. |
No change
640,882
|
$1,435,576,000 | 0.07% |
| Spero Therapeutics Inc |
No change
889,979
|
$1,156,973,000 | 0.06% |
| Exact Sciences Corp. |
No change
23,205
|
$980,411,000 | 0.05% |
| Alector, Inc. |
No change
175,866
|
$798,432,000 | 0.04% |
| Hyperfine Inc |
No change
898,720
|
$763,912,000 | 0.04% |
| Quince Therapeutics Inc |
No change
189,122
|
$141,842,000 | 0.01% |
| Fulcrum Therapeutics Inc |
No change
14,262
|
$88,424,000 | 0.00% |
| Repligen Corp. |
No change
383
|
$48,281,000 | 0.00% |
| Mondee Holdings Inc |
Closed
18,420
|
$42,550,000 | |
| Invitae Corp |
No change
235,606
|
$0 | 0.00% |
| Cue Health Inc |
No change
27,000
|
$0 | 0.00% |
| No transactions found | |||
| Showing first 500 out of 45 holdings | |||